Welcome to our dedicated page for Runway Growth Finance news (Ticker: RWAY), a resource for investors and traders seeking the latest updates and insights on Runway Growth Finance stock.
Runway Growth Finance Corp. (RWAY) operates as a specialty finance company providing flexible capital solutions to late- and growth-stage companies seeking an alternative to raising equity. Its lending and investment activity is tied to sectors such as technology, life sciences, healthcare information and services, business services, and select consumer industries.
Recurring company updates cover operating and financial results, portfolio investments and liquidity events, net asset value and investment income, quarterly cash distributions, dividend reinvestment practices, capital-structure matters, and governance developments. News also reflects the completed acquisition of SWK Holdings Corporation, which expanded Runway Growth's healthcare and life sciences exposure.
Runway Growth Finance Corp (Nasdaq: RWAY) said it will partially redeem its 7.50% Notes due 2027 and fully redeem its 8.00% Notes due 2027 on March 5, 2026. The company expects to redeem $40,250,000 of 7.50% Notes and $51,750,000 of 8.00% Notes.
The redemption price per note will be $25 plus accrued and unpaid interest from March 1, 2026 up to, but not including, the redemption date.
Runway Growth Finance (Nasdaq: RWAY) priced an underwritten public offering of $100.0 million aggregate principal amount of 7.25% notes due February 3, 2031, with expected net proceeds of approximately $97.0 million. The Notes pay interest quarterly, first payment on March 1, 2026, and may be redeemed on or after February 3, 2028. The company granted a 30-day option to purchase up to an additional $15.0 million of Notes for overallotments. Runway intends to use proceeds to repay outstanding indebtedness, including redeeming its 8.00% notes due 2027 ($51.75M) and its 7.50% notes due 2027 ($80.5M), and for general corporate purposes.
Runway Growth Finance (Nasdaq: RWAY) commenced an underwritten offering of unsecured notes on January 26, 2026, with plans to apply to list the Notes on the Nasdaq Global Select Market and, if approved, to begin trading within 30 days of original issue date. The interest rate and final terms will be set at pricing. Net proceeds are intended to repay outstanding indebtedness (including up to $51.75 million of 8.00% notes due December 28, 2027), finance the previously announced acquisition of SWK Holdings, and for general corporate purposes.
Joint book-running managers and co-managers have been engaged, and a preliminary prospectus supplement (dated January 26, 2026) and accompanying prospectus are filed with the SEC.
Runway Growth Finance (Nasdaq: RWAY) reported a fourth-quarter 2025 portfolio and transaction update. During Q4 the company funded $42.9 million across seven investments, including a $20.0M mobility deal, a $10.0M SPV commitment, and a $20.0M Shield Therapeutics facility (with $2.0M funded at close); follow-ons totaled $10.9M. Q4 liquidity events totaled $77.8M, driven by principal repayments from Synack ($45.0M) and Dejero Labs ($14.7M), an assignment of $15.0M in Kin Insurance, plus other repayments.
The pending acquisition of SWK Holdings is expected to close late Q1 2026 pending regulatory approvals; Runway filed a Form N-14 on Nov 18, 2025. As of Dec 31, 2025 the portfolio included 40 debt investments to 31 companies and 72 equity investments in 48 companies, with 24 companies holding both debt and equity positions.
Runway Growth Capital (NASDAQ: RWAY) announced that Ryan McCarthy joined the firm as Managing Director on Dec. 10, 2025. McCarthy will focus on sourcing, evaluating, and structuring growth loan opportunities across the technology and life sciences markets while deepening relationships with founders, management teams, and financial sponsors.
He brings nearly two decades of experience in venture debt, debt advisory, and investment banking, most recently as Managing Director at Capital Advisors Group, and previously at TriplePoint Capital, Headwaters MB, and Rutberg & Company. McCarthy holds an MBA and MSF from Boston College and a BA from Hamilton College and is based in Menlo Park.
Runway Growth Finance (Nasdaq: RWAY) reported third quarter 2025 results with total investment income $36.7M and net investment income $15.7M (or $0.43/share). Investment portfolio fair value $945.96M across 54 companies with a dollar-weighted annualized yield on debt investments of 16.8%. NAV $489.5M or $13.55/share (down 0.8% QoQ). Available liquidity totaled $371.9M and core leverage fell to ~92%. Company repurchased 397,983 shares for $4.4M and declared a $0.33/share dividend for Q4 2025. Post-quarter, Runway entered a merger agreement to acquire SWK Holdings to expand healthcare and life sciences exposure.
Runway Growth Finance Corp (Nasdaq: RWAY) announced a $0.33 per share cash distribution for the fourth quarter of 2025. Key dates: Declaration Date: November 5, 2025; Record Date: November 17, 2025; Payment Date: December 3, 2025.
The company said it generally intends to distribute substantially all available earnings on a quarterly basis, subject to Board discretion and conditions including the company’s earnings, financial condition, maintenance of regulated investment company status, and compliance with business development company regulations.
The company maintains an opt-out dividend reinvestment plan; stockholders not opted out will have cash dividends automatically reinvested in additional common shares.
Runway Growth Capital (NASDAQ:RWAY) was named to Inc. Magazine's 2025 Founder-Friendly Investors list for the third consecutive year, highlighting its focus on minimally dilutive growth loans that preserve founder ownership and control.
Key facts: Runway has partnered with >80 businesses and committed over $3.0 billion in loans since 2015. In January 2025 Runway was acquired by BC Partners Credit, aligning Runway with BC's $40 billion in assets under management while retaining its leadership team and credit culture.
Disclosure notes a paid entry fee for the award, which may create a conflict of interest.
Runway Growth Finance Corp (Nasdaq: RWAY) will release its Q3 2025 financial results after market close on Thursday, November 6, 2025.
The company will host a conference call and webcast the same day at 3:00 p.m. PT (6:00 p.m. ET). Participants are asked to register via the Runway Growth investor relations website, preferably a day before or at least 15 minutes before the call. A replay of the webcast will be available two hours after the call and archived on the same webpage for 90 days.
Runway Growth Finance (Nasdaq: RWAY) entered a definitive merger agreement to acquire SWK Holdings (Nasdaq: SWKH), a life‑science specialty finance firm, in an NAV‑for‑NAV transaction with an estimated purchase price of ~$220 million (including estimated transaction expenses).
Pro forma, the deal raises total assets to $1.3 billion, increases healthcare exposure to ~31% of the portfolio (from 14% as of 6/30/2025), and is expected to deliver mid‑single‑digit NII accretion in the first full quarter after close. Consideration includes $75.5 million in Runway Growth shares, ~$145 million in cash, and a $9 million adviser cash contribution. SWK’s portfolio (22 companies) has an approximate fair value of $242 million (est. 8/15/2025). The close is expected late 2025–Q1 2026, subject to approvals.